Bill Gates Pours Money into Computational Drug Design

genomeweb
360dx

Bill Gates Pours Money into Computational Drug Design

May 12, 2010

Bill Gates has invested $10 million in computational drug design company Schrödinger, Derek Lowe reports in a Nature News column.

To read the full story....

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

In Brief This Week: Baby Genes, J&J Innovation, Myriad Genetics, Merck, More
People in the News: Garret Lam, Kenneth Bloom, Joseph Caruso
Roche to Close NimbleGen Site, Lay Off 79 by Mid-2020
New Products Posted to GenomeWeb: Thermo Fisher Scientific, Twist Bioscience, 10X Genomics, More
LexaGene Announces C$5M Bought Deal Financing
Large Study Uncovers Genetic Connections Between Numerous Psychiatric Disorders

The Scan

Privacy Policy Information, Please

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

Moving the Parts About

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

This Week in Science

In Science this week: genetic overlap among many psychiatric disorders, and more.

Just Skip that Step

The Economist writes that an increasing number of scientific journals don't do peer review.

Main menu